NIH-Funded Study Finds Early HAART during TB Treatment Boosts Survival Rate in People Co-Infected with HIV and TB

NIH-Funded Study Finds Early HAART during TB Treatment Boosts Survival Rate in People Co-Infected with HIV and TB
A clinical trial in Cambodia has found it possible to prolong the survival of untreated HIV-infected adults with very weak immune systems and newly diagnosed tuberculosis (TB) by starting anti-HIV therapy two weeks after beginning TB treatment, rather than waiting eight weeks, as has been standard.
Read more on National Institutes of Health

DRUG COURTS, WHOSE AIM IS OFFENDER TREATMENT, GET RENO OFFICIALS’ ATTENTION.
“How many days have you been clean?” the judge asked a man who stood up among a crowd seated in a Se …
Read more on Hutchinson News